Sunscreens and insect repellents

Current Opinion in Pediatrics

Volumn 16, Issue 4, 2004, Pages 378-384

  Buka, Robert L ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYLHEXYL 4 METHOXYCINNAMATE OCTOCRYLENE; 4 AMINOBENZOIC ACID; AVOBENZONE; BENZOPHENONE; CAMPHOR DERIVATIVE; CINNAMIC ACID DERIVATIVE; CINOXATE; CITRONELLAL; DIETHYLTOLUAMIDE; ESTER DERIVATIVE; INSECT REPELLENT; IR 3535; METHANE; OXYBENZONE; PICARIDIN; SALICYLIC ACID DERIVATIVE; SUNSCREEN; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

CARCINOGENESIS; ERYTHEMA; HUMAN; PEDIATRICS; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION PROTECTION; REVIEW; SIDE EFFECT; SKIN CANCER; SKIN IRRITATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

ANIMALS; CHILD; DEET; ENVIRONMENTAL EXPOSURE; HUMANS; INSECT BITES AND STINGS; INSECT REPELLENTS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 3442899346     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000133082.32384.76     Document Type: Review

References (55)

1. Ting WW, Vest CD, Sontheimer R: Practical and experimental consideration of sun protection in dermatology. Int J Dermatol 2003, 42:505-513. Outstanding introduction of new and experimental agents on the forefront of sun protection. A must-read for those who wish to keep current of recent developments.
2. Hurwitz S: The sun and sunscreen protection: recommendations for children. J Dermatol Surg Oncol 1988, 14:657.
3. Kim HJ: Photoprotection in adolescents. Adolesc Med 2001, 12:181-193.
4. Geller AC, Colditz G, Oliveria S, et al.: Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 US children and adolescents. Pediatrics 2002, 109:1009-1014.
5. Moloney FJ, Collins S, Murphy GM: Sunscreens: safety, efficacy and appropriate use. Am J Clin Dermatol 2002, 3:181-191.
6. Lowe NJ, Friedlander J: Prevention of photodamage with sun protection and sunscreens. In Photodamage. Edited by Gilchrest BA. Cambridge: Blackwell Science; 1995:201-220.
7. Setlow RB, Grist E, Thompson K, et al.: Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A 1993, 90:6666-6670.
8. Freeman SE, Hacham H, Gange RW, et al.: Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci U S A 1989, 86:5605-5609.
9. Brash DE, Ziegler A, Jonason AS, et al.: Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol 1996, 1:136-142.
10. Ahrens C, Grewe M, Berneburg M, et al.: ICAM-1 expression and photocarcinogenesis in DNA repair defective individuals. Proc Natl Acad Sci USA 1997, 94:6837-6841.
11. Al Mahroos M, Yaar M, Phillips TJ, et al.: Effect of sunscreen application on UV-induced thymine dimers. Arch Dermatol 2002, 138:1480-1485.
12. Wolf P, Yarosh DB, Kripke ML: Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice. J Invest Dermatol 1993, 101:523-527.
13. Kligman LH, Akin FJ, Kligman AM: Sunscreens prevent ultraviolet photocarcinogenesis. J Am Acad Dermatol 1980, 3:30-35.
14. Plastow SR, Harrison JA, Young AR: Early changes in dermal collagen of mice exposed to chronic UVB irradiation and the effects of a UVB sunscreen. J Invest Dermatol 1988, 91:590-592.
15. Green A, Williams G, Neal R, et al.: Daily sunscreen application and beta carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 1999, 354:723-729.
16. U.S. Food and Drug Administration: Sunscreen drug products for over-the-counter human use: Final monograph. In: Anonymous. Federal Register. Washington, DC: Department of Health, Education and Welfare, Food and Drug Administration 1999, 27666-27693.
17. Debuys HV, Levy SB, Murray JC, et al.: Modern approaches to sun protection: dermatologic aspects. Cosmetics 2000, 18:577-590.
18. Wolf R, Matz H, Orion E, et al.: Sunscreens: the ultimate cosmetic. Acta Dermatovenerol Croat 2003, 11:158-162. Addresses chemical versus physical blocks as well as the question of reapplication.
19. http://www.telemedicine.org/sundam2.4.3.html (accessed May 1, 2004)
20. Autier P, Dore J, Negrier S, et al.: Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst 1999, 91:1304-1309.
21. Hunchrek M, Kupelnick B: Use of topical sunscreen and the risk of malignant melanoma: results of a meta-analysis of 9067 patients. AEP 2000, 10:467.
22. Wolf R, Wolf D, Pierfrancesco M, et al.: Sunscreens. Clin Dermatol 2001, 19:452-459.
23. Rosen C: Topical and systemic photoprotection. Derm Ther 2003, 16:8-15. A nice review of sunscreen options available for children. Includes a brief description of holistic options as well.
24. Ramirez R, Schneider J: Practical guide to sun protection. Surg Clin North Am 2003, 83:97-107. A comprehensive, definitive review of various fabrics and their respective SPFs.
25. http://www.skincancer.org/prevention/dress.html (accessed May 1, 2004). A nice review of various fabrics and their respective SPFs.
26. Bajdik CD, Gallagher RP, Hill GB, et al.: Sunlight exposure, hat use, and squamous cell skin cancer on the head and neck. J Cutan Med Surg 1998, 3:68-73.
27. Kim HJ: Photoprotection in adolescents. Adolesc Med 2001, 12:181-193.
28. Pathak MA: Sunscreens and their use in the preventative treatment of sunlight-induced skin damage. J Dermatol Surg Oncol 1987, 13:739.
29. O'Donoghue M: Sunscreens: update 2004. Cosm Derm 2004, 17:171-172. A very brief and insightful article on sunscreen options, broken down by respective light wavelengths.
30. Deflandre A, Lang G: Photostability assessment of sunscreens: benzylidene camphor and dibenzoylmethane derivatives. Int J Cosmet Sci 1988, 10:53-62.
31. Nohynek GJ, Schaefer H: Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol 2001, 33:285-299.
32. Duteil L, et al.: Assessment of a sunblock stick in the prevention of solar-simulating ultraviolet light-induced herpes labialis. J Dermatol Treat 1998, 9:11-14.
33. Diffey BL, Grice J: The influence of sunscreen type on photoprotection. Br J Dermatol 1997, 137:103-105.
34. American Academy of Pediatrics Committee on Environmental Health: Ultraviolet light: a hazard to children. Pediatrics 1999, 104:328-333.
35. Fraden MS, Day JF: Comparative efficacy of insect repellents against mosquito bites. N Eng J Med 2002, 347:13-18.
36. Sudakin DL, Trevathan WR: DEET: A review and update of safety and risk in the general population. Clin Tox. 2003, 41:831-839. A sharp denunciation of DEET use in children. Comprehensively reviews adverse event data eventuating in the continuance of this agent's use in children.
37. Brown M, Hebert AA: Insect repellents: an overview. J Am Acad Dermatol 1997, 36:243-249.
38. Nentwig G: Use of repellents as prophylactic agents. Parasitol Res 2003, 90:S40-S48. Wonderfully concise and seminal review of the current options. Includes molecular data, pseudonyms, and basic efficacy data.
39. Koren G, Matsui D, Benoit B: DEET-based insect repellents: safety implications for children and pregnant and lactating women. CMAJ 2003, 169:209-212. Outstanding, up-to-date review of the use of DEET in children as well as in lactating and pregnant women. Germane assessment of the overall safety of DEET products.
40. Peterson C: Insect repellent in urban settings. Biologist 2003, 50:39-43. A review of urban pests, including cockroaches and termites, which focuses on the epidemiologic impact of effective pest control.
41. USEPA: DEET reregistration eligibility decision (RED). EPA738-R-98-010. Washington DC: Office of Pesticide Programs, US Environmental Protection Agency, 1998.
42. Nevin R, Koren G: Missing Information on DEET. JAMC 2004, 170:14. An important glimpse of the controversy surrounding the toxicity of DEET in children.
43. Osimitz TG, Grothaus RH: The present safety assessment of DEET. J Am Mosquito Control Assoc 1995, 11:274-278.
44. Epidemiologic notes and reported seizures temporally associated with use of DEET insect repellents. MMWR 1989, 38:678-680.
45. Briassoulis G, Narlioglou M, Hatzis T: Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children. Hum Exp Toxicol 2001, 20:8-14.
46. Snyder JW, Row RO, Stubbins JF, et al.: Acute manic psychosis following the dermal application of N,N-diethyl-m-toluamide (DEET) in an adult. Clin Toxicol 1986, 24:429-439.
47. Fradin MS, Day JF: Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002, 347:13-18.
48. Fradin MS: www.emedicine.com/derm/topic540.htm (accessed May 1, 2004). A well-written introduction to the most-cited clinical trials supporting various repellent efficacies.
49. Insect repellents. Med Lett Drugs Ther 2003, 45:41-42.
50. Scheinfeld N: Picaridin: a new insect repellent. J Drugs Dermatol. 2004, 2:59-60. A concise review of the evidence behind picaridin as an effective alternative to DEET.
51. Frances SP, Van Dung N, Beebe NW, et al.: Field evaluation of repellent formulations against daytime and nighttime biting mosquitos in a tropical rainforest in northern Australia. J Med Entomol 2002, 39:541-544.
52. P-methane-3,8-diol [Proposed Regulatory Decision Document PRDD2002-02]. Ottawa: Pest Management Regulatory Agency, Health Canada 2002.
53. Hadis M, Mesfin L, Mekonnen Y, et al. Field trials of the repellent activity of four plant products against mainly mansonia population in western Ethiopia. Phytother Res 2003, 17:202-205. The leading and perhaps most elegant review of PMD as an effective repellent.
54. Evans MF: Which mosquito repellent works best? Can Fam Physician 2003, 49:983-984.
55. http://www.herbalglobal.com/line/default.asp?lid=178&name=green_ban (accessed May 1, 2004).